COMMUNIQUÉS West-GlobeNewswire

-
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
14/08/2025 -
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
14/08/2025 -
Ligand Announces Closing of Convertible Senior Notes Offering
14/08/2025 -
Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal
14/08/2025 -
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
14/08/2025 -
Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies
14/08/2025 -
Tecan issues CHF 150 million straight bond
14/08/2025 -
Press release: Transparency Notification from Shareholders
14/08/2025 -
U.S. Oral Surgery Management Moves into 31st State
14/08/2025 -
NIH Contract Expands DLH’s Position as a Digital Transformation and Cybersecurity Leader
14/08/2025 -
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025 -
Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025 -
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025 -
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025 -
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
14/08/2025 -
Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
14/08/2025 -
Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service
14/08/2025 -
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock
14/08/2025 -
Vaso Corporation Announces Financial Results for Second Quarter of 2025
14/08/2025
Pages